Quinidine plus verapamil vs. quinidine alone to prevent recurrences of atrial fibrillation

Comment

Henrique H Veloso et al. Eur Heart J. 2005 Aug.

. 2005 Aug;26(15):1568-9.

doi: 10.1093/eurheartj/ehi324. Epub 2005 May 17.

No abstract available

Comment on

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G; Prevention of Atrial Fibrillation after Cardioversion Investigators. Fetsch T, et al. Eur Heart J. 2004 Aug;25(16):1385-94. doi: 10.1016/j.ehj.2004.04.015. Eur Heart J. 2004. PMID: 15302102 Clinical Trial.
Quinidine rehabilitated and more lessons from the PAFAC and SOPAT anti-arrhythmic drug trials for the prevention of paroxysmal atrial fibrillation.
van Hemel N. van Hemel N. Eur Heart J. 2004 Aug;25(16):1371-3. doi: 10.1016/j.ehj.2004.06.027. Eur Heart J. 2004. PMID: 15321693 No abstract available.
Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.
Patten M, Maas R, Bauer P, Lüderitz B, Sonntag F, Dluzniewski M, Hatala R, Opolski G, Müller HW, Meinertz T; SOPAT Investigators. Patten M, et al. Eur Heart J. 2004 Aug;25(16):1395-404. doi: 10.1016/j.ehj.2004.06.014. Eur Heart J. 2004. PMID: 15321697 Clinical Trial.